Irritable Bowel Syndrome
Keywords: irritable bowel syndrome, IBS, gastrointestinal tract
AbstractIrritable bowel syndrome (IBS) is one of the most commonly diagnosed conditions affecting the gastrointestinal tract (GIT). Globally, approximately 15% of people suffer from IBS, while in South Africa the estimated prevalence is less than 10%. Despite advances in understanding this condition, it still remains a clinical challenge, and a common complaint in the pharmacy. Patients with IBS may be managed with lifestyle interventions and/or medicine, however, therapy should be individualised.
By submitting manuscripts to SAPA, authors of original articles are assigning copyright to the Publisher, Medpharm Publications (Pty) Ltd, unless otherwise specified. Authors may use their own work after publication without written permission, provided they acknowledge the original source. Individuals and academic institutions may freely copy and distribute articles published in SAPA for educational and research purposes without obtaining permission.